United Therapeutics Corporation · Drug Manufacturers - Specialty & Generic

UTHRUnited Therapeutics Corporation

Reports 2026-11-04 · WedReaction day 11-05upcoming

Before the print · expectationsReports today

No past prints on file yet.

Pricing going in · as of the 11-03 close

+11.0%Move over the last 20 sessionsLast 5 sessions +1.7%
+0.9 ptsvs sector (XLV)XLV over the same window +10.1%
—Forward P/EConsensus: not available

What the record doesn't tell you

Which way does UTHR go on 11‑04?

  • Model lean for 11-04, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-04

Revenue$833M
est. —
EPS—
est. —
Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

United Therapeutics earnings preview: what the record says

United Therapeutics (UTHR) is scheduled to report earnings on Nov 4, 2026.

NextPick tracks UTHR in its Biotech basket alongside VRTX, REGN, MRNA, BIIB, INCY, BNTX, ALNY and NBIX, whose prints read through to this one.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

UTHR earnings: key questions

When is UTHR's next earnings date?

United Therapeutics is scheduled to report on Nov 4, 2026.